Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer. | BMC Cancer | 2024 | 38263004 | PubTator, text mining | PubMed |
| The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes. | Biomedicines | 2024 | 38255301 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment. | Biomedicines | 2024 | 38255228 | PubTator, text mining | PubMed |
| It Takes Two to Tango: The Interplay between Prostate Cancer and Its Microenvironment from an Epigenetic Perspective. | Cancers (Basel) | 2024 | 38254784 | PubTator, text mining | PubMed |
| Breakthrough of solid tumor treatment: CAR-NK immunotherapy. | Cell Death Discov | 2024 | 38245520 | PubTator, text mining | PubMed |
| Identification of HSP90B1 in pan-cancer hallmarks to aid development of a potential therapeutic target. | Mol Cancer | 2024 | 38243263 | PubTator, text mining | PubMed |
| Small noncoding RNAs and sperm nuclear basic proteins reflect the environmental impact on germ cells. | Mol Med | 2024 | 38243211 | PubTator, text mining | PubMed |
| Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside. | Cell Death Dis | 2024 | 38221520 | PubTator, text mining | PubMed |
| Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications. | Virol J | 2024 | 38216935 | PubTator, text mining | PubMed |
| Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers. | Stem Cell Reports | 2024 | 38215755 | PubTator, text mining | PubMed |
| Linc-ROR inhibits NK cell-killing activity by promoting RXRA ubiquitination and reducing MICB expression in gastric cancer patients. | J Cell Biochem | 2024 | 38205878 | PubTator, text mining | PubMed |
| Cancer vaccines in the clinic. | Bioeng Transl Med | 2024 | 38193112 | PubTator, text mining | PubMed |
| Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. | J Immunother Cancer | 2024 | 38191242 | PubTator, text mining | PubMed |
| Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors. | Cancer Immunol Immunother | 2024 | 38180524 | PubTator, text mining | PubMed |
| Systematic analysis of the prognostic value and immunological function of LTBR in human cancer. | Aging (Albany NY) | 2024 | 38175686 | PubTator, text mining | PubMed |
| PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma. | Oncoimmunology | 2024 | 38125723 | PubTator, text mining | PubMed |
| Lymphocyte subsets and soluble forms of MIC-A and MIC-B are prognostic factors in non-Hodgkin lymphoma patients. | Ann Hematol | 2024 | 38091053 | PubTator, text mining | PubMed |
| Factors Defining Human Adipose Stem/Stromal Cell Immunomodulation in Vitro. | Stem Cell Rev Rep | 2024 | 37962697 | PubTator, text mining | PubMed |
| Identification of a novel MICB allele, MICB*014:02, by cloning and sequencing. | HLA | 2024 | 37933717 | PubTator, text mining | PubMed |
| MICB Genomic Variant Is Associated with NKG2D-mediated Acute Lung Injury and Death. | Am J Respir Crit Care Med | 2024 | 37878820 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=9